These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


363 related items for PubMed ID: 22995024

  • 1. Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials.
    Savarese G, Paolillo S, Costanzo P, D'Amore C, Cecere M, Losco T, Musella F, Gargiulo P, Marciano C, Perrone-Filardi P.
    J Am Coll Cardiol; 2012 Sep 25; 60(13):1192-201. PubMed ID: 22995024
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bosentan therapy in patients with pulmonary arterial hypertension: the relationship between improvements in 6 minute walk distance and quality of life.
    Strange G, Keogh AM, Williams TJ, Wlodarczyk J, McNeil KD, Gabbay E.
    Respirology; 2008 Sep 25; 13(5):674-82. PubMed ID: 18713089
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy in pulmonary arterial hypertension: a meta-analysis.
    Bai Y, Sun L, Hu S, Wei Y.
    Cardiology; 2011 Sep 25; 120(3):157-65. PubMed ID: 22212696
    [Abstract] [Full Text] [Related]

  • 6. Haemodynamics, exercise capacity and clinical events in pulmonary arterial hypertension.
    Savarese G, Musella F, D'Amore C, Losco T, Marciano C, Gargiulo P, Rengo G, Dellegrottaglie S, Bossone E, Leosco D, Perrone-Filardi P.
    Eur Respir J; 2013 Aug 25; 42(2):414-24. PubMed ID: 23100502
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.
    Benza RL, Gomberg-Maitland M, Naeije R, Arneson CP, Lang IM.
    J Heart Lung Transplant; 2011 Sep 25; 30(9):982-9. PubMed ID: 21531577
    [Abstract] [Full Text] [Related]

  • 9. Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension.
    Provencher S, Chemla D, Hervé P, Sitbon O, Humbert M, Simonneau G.
    Eur Respir J; 2006 Jan 25; 27(1):114-20. PubMed ID: 16387943
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Early decline in six-minute walk distance from the time of diagnosis predicts clinical worsening in pulmonary arterial hypertension.
    Huang J, Mehta S, Mura M.
    Respiration; 2015 Jan 25; 89(5):365-73. PubMed ID: 25791910
    [Abstract] [Full Text] [Related]

  • 12. Characterization of pulmonary arterial hypertension patients walking more than 450 m in 6 min at diagnosis.
    Degano B, Sitbon O, Savale L, Garcia G, O'Callaghan DS, Jaïs X, Humbert M, Simonneau G.
    Chest; 2010 Jun 25; 137(6):1297-303. PubMed ID: 20118205
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heart rate recovery predicts clinical worsening in patients with pulmonary arterial hypertension.
    Minai OA, Gudavalli R, Mummadi S, Liu X, McCarthy K, Dweik RA.
    Am J Respir Crit Care Med; 2012 Feb 15; 185(4):400-8. PubMed ID: 22108205
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis.
    Minai OA, Santacruz JF, Alster JM, Budev MM, McCarthy K.
    Respir Med; 2012 Nov 15; 106(11):1613-21. PubMed ID: 22902266
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I, Manlhiot C, Reyes J, McCrindle BW, Humpl T, Friedberg MK.
    Am Heart J; 2011 Sep 15; 162(3):562-8. PubMed ID: 21884877
    [Abstract] [Full Text] [Related]

  • 19. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC, Highland KB, Silver RM, Strange C.
    J Rheumatol; 2009 Feb 15; 36(2):330-6. PubMed ID: 19208563
    [Abstract] [Full Text] [Related]

  • 20. [Efficacy and safety of sildenafil therapy in pulmonary artery hypertension: a meta-analysis].
    Kuang TG, Wang J, Zhai ZG, Guo XH, Wang C.
    Zhonghua Yi Xue Za Zhi; 2007 Apr 17; 87(15):1021-4. PubMed ID: 17672963
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.